| Term 
 
        | benzodiazepine antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | non-benzodiazepine agonists that act at alpha-1 subunit |  | Definition 
 
        | eszopiclone, zaleplon,
 zolpidem
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | all end in "lam/pam?" except for chlordiazepoxide |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | more intense than stage 3...delta/slow-wave sleep |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased heart rate, muscle paralysis,
 intense dreaming
 |  | 
        |  | 
        
        | Term 
 
        | normal sleep cycle pattern |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | benzodiazepines modulate... |  | Definition 
 
        | GABA receptor, and they REQUIRE GABA for action |  | 
        |  | 
        
        | Term 
 
        | benzodiazepines effetcs on sleep |  | Definition 
 
        | increase time in stage 2, decrease time in stage 1,3,4 and REM
 increase number of REM cycles
 |  | 
        |  | 
        
        | Term 
 
        | cautions with benzodiazepines |  | Definition 
 
        | children, ethanol,
 impaired liver function,
 sleep-related breathing disorders
 |  | 
        |  | 
        
        | Term 
 
        | benzodiazepines and cardiovascular |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | benzodiazepines drug interactions |  | Definition 
 
        | cimetidine, oral contraceptives, drugs that require CYP3A4
 |  | 
        |  | 
        
        | Term 
 
        | the ideal hypnotic agent from benzodiazepines |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | intermediate acting benzos |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | flurazepam, diazepam, quazepam |  | 
        |  | 
        
        | Term 
 
        | benzodiazepine agonists that are approved for 7-10 day treatment |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | causes morning sedation, and concerns with next day driving |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1st and only drug indicated for chronic treatment of insomnia |  | Definition 
 
        | eszopiclone...alcohol exacerbates |  | 
        |  | 
        
        | Term 
 
        | used for benzodiazepine overdose, to reverse sedative effects |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | barbiturates sleep stage effects |  | Definition 
 
        | decrease REM and stage 3-4 sleep, increase total sleep time,
 decrease sleep latency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GABA A receptor, AMPA receptor antagonist
 |  | 
        |  | 
        
        | Term 
 
        | barbiturates side effects |  | Definition 
 
        | hangover, increased pain perception, depressed respiration,
 decreased BP and HR,
 inhibit steroid metabolism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | given orally, delayed by food
 |  | 
        |  | 
        
        | Term 
 
        | barbiturates contraindications |  | Definition 
 
        | porphyria, pulmonary insufficiency |  | 
        |  | 
        
        | Term 
 
        | higher abuse rate and lower TI than benzos |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | melatonin receptor agonist, useful for delayed sleep onset,
 approved for long-term use,
 side effects of amenorrhea, nipple discharge
 |  | 
        |  | 
        
        | Term 
 
        | ramelteon drug interactions/contraindications |  | Definition 
 
        | fluvoxamine/ketoconazole will INCREASE concentration, rifampin will DECREASE concentration
 contraindicated in liver/pulmonary disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | orexin receptor 1 and 2 antagonist, causes impaired day time wakefulness(sleep driving)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | <3 days, use lowest dose hypnotic for 2-3 days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3 days to 3 weeks, hypnotic intermittently for 7-10 days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | >3 weeks, try nonpharmacological treatments first
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | if using a short-acting benzo, then first switch to a long-acting benzo and taper off |  | 
        |  |